HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in the Symptoms and VEGF Levels after Resection of an Extrame Dullary Spinal Tumor and Additional Chemotherapy in a Patient with Multiple Myeloma Complicated with POEMS Syndrome.

Abstract
We herein report a case of multiple myeloma and polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes (POEMS) syndrome. The patient experienced exacerbated gait disturbance due to weakness and numbness in the lower limbs. Thoracic magnetic resonance imaging revealed an extramedullary tumor with spinal compression that required surgical resection. Plasmacytoma was diagnosed based on a biopsy. Radiation, betamethasone, and chemotherapy were therefore administered. Surgical removal of extramedullary tumors improved his symptoms, motor conduction velocity, and amplitude of the muscle action potential in the peroneal and tibial nerves, as shown by the nerve conduction study. Surgery also decreased the serum vascular endothelial growth factor levels. The patient required additional chemotherapy due to multiple myeloma and showed better outcomes nine months after discharge. The benefits of some treatments remain controversial due to the small number of patients. However, our findings reveal that an early diagnosis and comprehensive treatment may result in better outcomes in such patients.
AuthorsMariko Sano, Tatou Iseki, Makoto Sasaki, Yutaka Tsukune, Hajime Yasuda, Kazo Kanazawa, Atsushi Arakawa, Kazumasa Yokoyama, Norio Komatsu, Nobutaka Hattori, Kenya Nishioka
JournalInternal medicine (Tokyo, Japan) (Intern Med) Vol. 60 Issue 22 Pg. 3625-3630 ( 2021) ISSN: 1349-7235 [Electronic] Japan
PMID34776466 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vascular Endothelial Growth Factor A
Topics
  • Humans
  • Multiple Myeloma (complications, drug therapy)
  • POEMS Syndrome (complications, drug therapy)
  • Spinal Cord Neoplasms
  • Spinal Neoplasms (complications, drug therapy, surgery)
  • Vascular Endothelial Growth Factor A

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: